Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department

Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department

Background/Purpose: Although illicit substance use-induced toxicity or complication is a frequent cause of visit to the emergency department (ED), there are limited data on cases confirmed by liquid chromatography tandem-mass spectrometry (LC-MS/MS) analysis. This study aimed to describe clinical pr...

Full description

Bibliographic Details
Main Authors:	Te-I Weng, Lian-Yu Chen, Ju-Yu Chen, Pai-Shan Chen, Hsaio-Lin Hwa, Cheng-Chung Fang
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Journal of the Formosan Medical Association
Subjects:	Illicit abused substance New psychoactive substance Cathinone Emergency department
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664620300097

Similar Items

Gender differences in clinical characteristics of emergency department patients involving illicit drugs use with analytical confirmation
by: Te- I. Weng, et al.
Published: (2022-09-01)

A Photoluminescent Colorimetric Probe of Bovine Serum Albumin-Stabilized Gold Nanoclusters for New Psychoactive Substances: Cathinone Drugs in Seized Street Samples
by: Yao-Te Yen, et al.
Published: (2019-08-01)

Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017
by: Patrizia Verri, et al.
Published: (2019-09-01)

New psychoactive substances and the risks of consumption in children and adolescents
by: Viorela Nitescu
Published: (2019-12-01)

Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use
by: Yu-Hsiung Chen, et al.
Published: (2022-11-01)

Preliminary Detection of New Psychoactive Substances (NPS) in Synthetic Drugs Seizures in the Northeast Brazil in a Period of Two Years (2014–2016)
by: Ricardo Leal Cunha, et al.
Published: (2017-03-01)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
by: Monia Lenzi, et al.
Published: (2023-06-01)

Editorial: Pharmacology of new psychoactive substances
by: K. Lutfy, et al.
Published: (2023-05-01)

Editorial: Old and new psychoactive substances: Pharmacology and potential applications
by: Felix P. Mayer, et al.
Published: (2023-01-01)

Mephedrone – a synthetic derivative of cathinone
by: Bielecka-Papierz Gabriela, et al.
Published: (2023-03-01)

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
by: Gniewko Więckiewicz, et al.
Published: (2023-07-01)

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
by: Hsin-Tzu Yeh, et al.
Published: (2022-07-01)

First-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation
by: Elisabet Teixidó, et al.
Published: (2023-09-01)

Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018
by: Abdullah Al-Matrouk, et al.
Published: (2021-04-01)

Cigarette Smoking, Illicit Medicine, Substance and Alcohol Abuseamong Pregnant Women: A Cross Sectional Study from Iran
by: Sedigheheh Sadat Tavafian, et al.
Published: (2008-05-01)

Basin-scale exposure risk of psychiatric pharmaceuticals and illicit drugs in tap water in Eastern China
by: Wei Wang, et al.
Published: (2024-09-01)

Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences
by: Augusta Pisanu, et al.
Published: (2022-09-01)

Fatal cases involving new psychoactive substances and trends in analytical techniques
by: Ettore Ferrari Júnior, et al.
Published: (2022-10-01)

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
by: Stefania Chiappini, et al.
Published: (2021-06-01)

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative
by: Karolina E. Kolaczynska, et al.
Published: (2021-07-01)

Psychoactive substance abuse amongst an urban secondary school population in Enugu, Nigeria: Prevalence and pattern of use
by: K O B. Okonkwo, et al.
Published: (1999-01-01)

Smoking, alcohol consumption, and illicit substances use among adolescents in Poland
by: Maria Nowak, et al.
Published: (2018-11-01)

The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier properties
by: Tetyana P. Buzhdygan, et al.
Published: (2021-03-01)

New psychoactive substances abuse and its clinical consequences - the case report
by: Andrzej Kościuk, et al.
Published: (2019-08-01)

Relationship between GABA-Ergic System and the Expression of Mephedrone-Induced Reward in Rats—Behavioral, Chromatographic and In Vivo Imaging Study
by: Olga Wronikowska-Denysiuk, et al.
Published: (2023-06-01)

A Quantitative LC–MS/MS Method for the Detection of 16 Synthetic Cathinones and 10 Metabolites and Its Application to Suspicious Clinical and Forensic Urine Samples
by: Abdulaziz A. Aldubayyan, et al.
Published: (2022-04-01)

Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
by: Benoit Schreck, et al.
Published: (2020-07-01)

The Hazardous Use Scale of psychoactive substances. A pilot study
by: Robert Modrzyński, et al.
Published: (2023-02-01)

Attitudes and Associated Demographic Factors Contributing towards the Abuse of Illicit Drugs: A Cross-Sectional Study from Health Care Students in Saudi Arabia
by: Wajid Syed, et al.
Published: (2022-02-01)

Structure Assignment of Seized Products Containing Cathinone Derivatives Using High Resolution Analytical Techniques
by: João L. Gonçalves, et al.
Published: (2021-02-01)

From the Streets to the Judicial Evidence: Determination of Traditional Illicit Substances in Drug Seizures by a Rapid and Sensitive UHPLC-MS/MS-Based Platform
by: Fabio Gosetti, et al.
Published: (2022-12-01)

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
by: Udo Bonnet, et al.
Published: (2020-10-01)

Diagnosis and management of the patient with contaminated illicit drug poisoning
by: Richard M. Pino, et al.
Published: (2023-10-01)

Substances psychoactives : consomation, abus et dépendance
by: Joyce Oxenham, et al.
Published: (2023-09-01)

Simultaneous identification of abused drugs, benzodiazepines, and new psychoactive substances in urine by liquid chromatography tandem mass spectrometry
by: Hei-Hwa Lee, et al.
Published: (2016-03-01)

Neuropsychopharmacology of Emerging Drugs of Abuse: <i>meta</i>- and <i>para</i>-Halogen-Ring-Substituted α-PVP (“<i>flakka</i>”) Derivatives
by: Núria Nadal-Gratacós, et al.
Published: (2022-02-01)

Toxicological Analysis of Illicit Drugs Seized in Naples (Italy) and First Detection of Synthetic Cannabinoids during COVID-19 Pandemic
by: Anna Carfora, et al.
Published: (2022-08-01)

New Challenges in the Narcotics World
by: Nicoleta-Elena Buzatu
Published: (2011-05-01)

Abuse Potential of Cathinones in Humans: A Systematic Review
by: Lourdes Poyatos, et al.
Published: (2022-02-01)

Prevalence of binge drinking and illicit substance use in patients hospitalized for psychiatric disorders
by: Barrios-Ayola Francisco, et al.
Published: (2012-06-01)